Rigby W, Buckner JH, Louis Bridges S Jr, Nys M, et al. HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA. Arthritis Res Ther 2021;23:245.
PMID: 34537057